BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 26595821)

  • 1. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
    Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
    Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms.
    Pardal J; Sundram U; Selim MA; Hoang MP
    Am J Dermatopathol; 2017 Apr; 39(4):279-286. PubMed ID: 28323779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors.
    Thamboo TP; Tan LH; Tan SY
    J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma.
    Plumb SJ; Argenyi ZB; Stone MS; De Young BR
    Am J Dermatopathol; 2004 Dec; 26(6):447-51. PubMed ID: 15618924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
    Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
    Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA3 staining in primary cutaneous apocrine cribriform carcinoma: Usefulness to differentiate it from breast cancer metastasis.
    Llamas-Velasco M; Pérez-Gónzalez YC; Daudén E; Rütten A
    J Cutan Pathol; 2018 May; 45(5):348-351. PubMed ID: 29431200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
    Plaza JA; Ortega PF; Stockman DL; Suster S
    J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA3 immunohistochemical expression in salivary gland neoplasms.
    Schwartz LE; Begum S; Westra WH; Bishop JA
    Head Neck Pathol; 2013 Dec; 7(4):311-5. PubMed ID: 23604756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.
    Miettinen M; McCue PA; Sarlomo-Rikala M; Rys J; Czapiewski P; Wazny K; Langfort R; Waloszczyk P; Biernat W; Lasota J; Wang Z
    Am J Surg Pathol; 2014 Jan; 38(1):13-22. PubMed ID: 24145643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Skin adnexal and salivary gland neoplasms. Similarities and differences of selected patients].
    Mentzel T
    Pathologe; 2004 Feb; 25(1):79-88. PubMed ID: 14767616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
    Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
    J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sox10 and DOG1 Expression in Primary Adnexal Tumors of the Skin.
    Lezcano C; Ho J; Seethala RR
    Am J Dermatopathol; 2017 Dec; 39(12):896-902. PubMed ID: 28394798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma.
    Scott MP; Helm KF
    Am J Dermatopathol; 1999 Feb; 21(1):16-20. PubMed ID: 10027519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of CD23 in cutaneous non-lymphoid neoplasms.
    Carvalho J; Fullen D; Lowe L; Su L; Ma L
    J Cutan Pathol; 2007 Sep; 34(9):693-8. PubMed ID: 17696916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a sensitive and specific marker to discriminate sebaceous proliferations from other cutaneous clear cell neoplasms.
    Uhlenhake EE; Clark LN; Smoller BR; Shalin SC; Gardner JM
    J Cutan Pathol; 2016 Aug; 43(8):649-56. PubMed ID: 27153339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases.
    Ostler DA; Prieto VG; Reed JA; Deavers MT; Lazar AJ; Ivan D
    Mod Pathol; 2010 Apr; 23(4):567-73. PubMed ID: 20118912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin.
    Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ
    J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 expression in sweat gland tumors.
    Biernat W; Woźniak L
    Pol J Pathol; 1996; 47(1):3-6. PubMed ID: 8705267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
    Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
    Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive immunostaining of claudin-4 in spiradenomas.
    Yiğit N; Çelik E; Yavan İ; Günal A; Kurt B; Karslıoğlu Y; Öngürü Ö; Özcan A
    Ann Diagn Pathol; 2016 Feb; 20():44-7. PubMed ID: 26616722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.